Cantor Fitzgerald Starts Hologic (HOLX) at Hold; Too Many Near-Term Challenges

Cantor Fitzgerald initiates coverage on Hologic (NASDAQ: HOLX) with a Hold. PT $18.00.

Cantor analyst said, "Ordinarily, the launch of a potentially game-changing technology like 3D tomo would warrant a BUY rating, but too many mitigating factors exist in this situation for that to be the case, and we do not necessarily see any near-term fixes. We would wait for either a better entry point or a catalyst (namely tomo reimbursement) to move numbers higher materially."

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $17.53 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• BMO Capital Starts Energy Fuels (UUUU) at Outperform